How GLP-1 drugs might affect the skin If you're dealing with unwanted skin changes due to extreme weight loss from a GLP-1, you're not alone
However, the evidence supporting their use specifically in patients post-bariatric surgery remains limited, with findings from individual studies not yet justifying widespread clinical adoption
Read our full article to understand the changes, key timelines, and what they mean for your labeling strategy: #FoodLabeling #FDA #Compliance #EurofinsFoodAssurance #FoodIndustry #Labeling To view or add a comment, sign in The $70 Billion Problem Nobody's Talking About I just released my interview with Jordan Glenn, Head of Science at SuppCo, and what he revealed about the supplement industry is deeply concerning
GLP-1 activates a seven transmembrane G protein coupled receptor, GLP-1R
The existing amylin analogue pramlintide (sold as Symlin in the US for diabetes management) requires multiple daily injections